Mecasermin Completed Phase 1 Trials for Rett's Syndrome Treatment

IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT01253317Treatment of Rett Syndrome With rhIGF-1 (Mecasermin [rDNA]Injection)